OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $157,000 | -65.2% | 91,250 | -57.3% | 0.00% | -60.0% |
| Q3 2015 | $451,000 | -19.2% | 213,700 | +89.6% | 0.01% | 0.0% |
| Q2 2015 | $558,000 | -88.8% | 112,700 | -82.3% | 0.01% | -90.0% |
| Q1 2015 | $4,989,000 | +95.5% | 637,176 | +51.3% | 0.05% | +194.1% |
| Q4 2014 | $2,552,000 | +9.4% | 421,103 | -23.1% | 0.02% | +41.7% |
| Q3 2014 | $2,333,000 | +69.7% | 547,716 | +146.2% | 0.01% | +71.4% |
| Q2 2014 | $1,375,000 | -20.0% | 222,500 | -15.9% | 0.01% | -22.2% |
| Q1 2014 | $1,718,000 | +381.2% | 264,457 | +316.0% | 0.01% | +350.0% |
| Q4 2013 | $357,000 | +207.8% | 63,568 | +236.1% | 0.00% | +100.0% |
| Q3 2013 | $116,000 | – | 18,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $6,085,000 | 40.17% |
| Foresite Capital Management II, LLC | 4,200,047 | $20,790,000 | 7.30% |
| Scale Management, LLC | 1,560,775 | $7,726,000 | 5.03% |
| Cheyne Capital Management (UK) LLP | 1,484,045 | $7,339,000 | 2.37% |
| NEA Management Company, LLC | 3,709,000 | $18,360,000 | 0.96% |
| Partner Investment Management, L.P. | 127,345 | $630,000 | 0.89% |
| GREAT POINT PARTNERS LLC | 440,000 | $2,178,000 | 0.85% |
| PFM Health Sciences, LP | 5,278,672 | $26,129,000 | 0.66% |
| Rock Springs Capital Management LP | 1,550,000 | $7,673,000 | 0.56% |
| Telemetry Investments, L.L.C. | 250,000 | $1,238,000 | 0.56% |